Skip to content
Log in
Sponsored Have an interesting project or opportunity? → Hire me ↗
Sponsored Artificial Intelligence: A Modern Approach, Global Edition Artificial Intelligence: A Modern Approach, Global Edition

Shared Genetic Architecture of Epilepsy and Glioma Revealed by Mendelian Randomization: Identifying Prognostic Biomarkers and Therapeutic Targets.

Xiangling Feng Jiahao Zhou Zhen He Xiaomin Ying Tongtong Kan
Jul 2026 · Current Cancer Drug Targets · 0 citations
Medicine

TL;DR

These findings support a neuroimmune model in which pleiotropic germline variants act via microglia and excitatory neurons to link seizure biology with tumor immunity and prognosis, and reveal a common genetic architecture between glioma and epilepsy.

Abstract

Background

Glioma-Related Epilepsy (GRE) is a hallmark comorbidity of Low-Grade Glioma (LGG), yet the cellular and molecular mechanisms through which germline epilepsy susceptibility converges with tumor biology to shape clinical outcomes remain poorly understood.

Methods

Genome-Wide Association Studies (GWAS), expression quantitative trait loci (eQTL) data, single-cell RNA sequencing, and spatial transcriptomics were integrated. Causal inference, phenotype-driven single-cell analyses, and machine learning were applied to identify genetically informed cellular mechanisms underlying GRE.

Results

A total of 68 germline loci shared by glioma and epilepsy (FDRIVW < 0.05) were integrated, with microglia and excitatory neurons as the principal mediating cell types. Four seizure-associated genes (WFIKKN1, WDSUB1, SPARCL1, and CALD1) were subsequently identified in TCGA-LGG, with high-confidence enhancer-promoter support for three of them (colco.PP4 > 0.9). A four-gene signature consistently stratified overall survival across three independent cohorts (TCGA-LGG, CGGA_325, and GSE16011) and correlated with immune checkpoint gene expression. High-risk patients showed higher sensitivity to cyclopamine, according to in silico drug response.

Discussion

These findings support a neuroimmune model in which pleiotropic germline variants act via microglia and excitatory neurons to link seizure biology with tumor immunity and prognosis. At the same time, in silico therapeutic predictions require functional and multi-ancestry validation.

Conclusion

These results reveal a common genetic architecture between glioma and epilepsy, offering candidate biomarkers and therapeutic strategies for the management of GRE.

DOI PubMed Semantic Scholar
View source

Similar papers

Open access Aug 2026

Brain single-cell transcriptome-informed Mendelian randomization identifies potential druggable therapeutic targets for Alzheimer's disease

A brain cell type-resolved genetic prioritization framework for AD is provided, nominating genetically supported candidate druggable targets and linking them to neurodegenerative and immune-related pathways.

Ren-Jun Huang, Li-Qing Guan, Yang Chen et al. · 0 citations
Review Open access Aug 2026

The genetic architecture of epilepsy across molecular mechanisms and clinical heterogeneity

This review synthesizes contemporary insights into the genetic and molecular pathophysiology of seizures and epilepsy, with emphasis on mechanisms that destabilize excitation–inhibition balance, promote epileptogenesis, and drive pharmacoresistance and supports more refined approaches to epilepsy classification and future precision medicine strategies.

Mohammad Reza Seyedtaghia, Jina Babanzadeh, Marcello Scala et al. · 0 citations
Open access Jul 2026

Causal association and shared mechanisms between Graves' disease and prostate cancer: insights from Mendelian randomization, machine learning, and comprehensive bioinformatics.

This study provided novel insights into the protective effect of GD against PCa and identified shared genes and immune mechanisms, offering a deeper understanding of the common mechanisms between GD and PCa.

Mingshun Zuo, Yuanjian Liao, Qiang Xu et al. · 0 citations
Open access Jul 2026

Imaging-mediated genetic effects link brain microstructure, metabolic profiles, and regional transcription to glioma susceptibility

Robust multi-layered evidence is provided for the causal roles of white matter microstructural abnormalities, metabolic dysregulation, and regional gene expression in glioma development and indicates that significant regional genes are heavily involved in DNA metabolism and cell cycle pathways.

Yufan Wu, Xuezhen Wang, Xinkai Wang et al. · 0 citations
Open access Jul 2026

Shared genetic architecture between schizophrenia and subcortical brain susceptibility phenotypes.

Schizophrenia (SCZ) is a highly heritable and complex neuropsychiatric disorder. Emerging evidence implicates dysregulated brain iron, particularly in subcortical regions, in SCZ pathophysiology. Here, we systematically dissected the shared genetic architecture between SCZ and subcortical brain susceptibility phenotypes by integrating large-scale genome-wide association study (GWAS) data with quantitative susceptibility mapping (QSM) phenotypes across 16 subcortical regions. Using the MiXeR framework, we quantified the extent and pattern of shared genetic overlap between SCZ and each QSM phenotype, revealing the strongest overlap in the left and right nucleus accumbens. Conditional and conjunction false discovery rate analyses identified 666 unique shared SNPs. Functional annotation highlighted enrichment in pathways related to synaptic function and neuronal development, with pronounced expression in neurons. Additionally, we characterized their spatio-temporal expression patterns of shared genes and identified 89 significant expression-trait associations linked to SCZ-related phenotypes. Furthermore, the virtual drug screen identified 691 potential protein-drug pairs that may contribute to both iron regulation and SCZ. Our findings provide new insights into the complex interaction between subcortical brain susceptibility phenotypes and SCZ, highlighting pathways that may offer novel therapeutic strategies for SCZ and related brain susceptibility-associated conditions.

Yingying Xie, Jiaojiao Du, Yao Zhao et al. · 0 citations